tiprankstipranks
Trending News
More News >
Alphamab Oncology (HK:9966)
:9966
Hong Kong Market

Alphamab Oncology (9966) Revenue

Compare
1 Followers

Alphamab Oncology Revenue

Alphamab Oncology had a revenue of 466.52M in the quarter ending Dec 31, 2024, with 168.79%. This bring the company's revenue in the last twelve months to 640.08M, Decreased 150.16%. In the fiscal year ending Dec 31, 2024, Alphamab Oncology had annual revenue of 640.08M with 192.58% growth.
Revenue (ttm)
640.08M
Revenue Growth
185.36%
P/S Ratio
10.45
Revenue/Employee
HK$1,524,007
Employees
420
Market Cap
HK$6.69B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
640.08M421.31M+192.58%
Dec 31, 2023
218.77M51.93M+31.12%
Dec 31, 2022
166.84M20.82M+14.26%
Dec 31, 2021
146.02M+∞%
Dec 31, 2020
0.00-4.99M-100.00%
Dec 31, 2019
4.99M5.73M-779.18%
Dec 31, 2018
-735.00K-1.96M-160.10%
Dec 31, 2017
1.22M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis